Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Santiago de Compostela
Clinical trial register · Spain

Clinical Trials in Santiago de Compostela, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 188 Madrid 183 Seville 71 Málaga 66 Valencia 60
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona188 Madrid183 Seville71 Málaga66 Valencia60
All 103 locations
Target enrolment
to

Trials with a site in Santiago de Compostela

21 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
AstraZeneca
Phase 3
4,500
A Coruña, Almería, Badalona, Barcelona, León, Madrid, Santander, Santiago de Compostela
2026-06-29
Recruiting
AstraZeneca
Phase 3
670
Barcelona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Santiago de Compostela
2026-05-04
Recruiting
AstraZeneca
Phase 3
2,130
Barcelona, Madrid, Pamplona, Santander, Santiago de Compostela, Valencia
2026-02-03
Recruiting
AstraZeneca
Phase 2
320
Barcelona, Málaga, Sabadell, Santiago de Compostela, Valencia
2025-12-15
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
AstraZeneca
Phase 2
150
Barcelona, Girona, Las Palmas de Gran Canaria, Lugo, Madrid, Santiago de Compostela
2025-05-15
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
AstraZeneca
Phase 1/2
408
Barcelona, Madrid, Palma de Mallorca, Santiago de Compostela, Valencia
2025-01-30
Active, closed
AstraZeneca
Phase 3
181
Barcelona, Cadiz, Madrid, Salamanca, Santiago de Compostela
2024-12-03
Active, closed
AstraZeneca
Phase 2
194
A Coruña, Alcorcón, Barcelona, Madrid, Málaga, Pamplona, Santander, Santiago de Compostela
2024-08-27
Recruiting
AstraZeneca
Phase 3
100
Esplugues de Llobregat, Madrid, Málaga, Santiago de Compostela, Valencia
2024-03-14
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Santiago de Compostela, Zaragoza, Poniente Sur, Santander, Burgos, Ourense, Majadahonda, El Palmar
2023-12-20
Active, closed
AstraZeneca
Phase 3
1,902
Barcelona, Granada, Hospitalet deLlobregat, Madrid, Santiago de Compostela, Seville, Zaragoza
2023-11-14
Active, closed
AstraZeneca
Phase 3
53
Badalona, Santiago de Compostela, Seville
2022-07-01
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Barcelona, Madrid, Málaga, Santiago de Compostela, Seville
2022-05-23
Active, closed
AstraZeneca
Phase 3
644
Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Santiago de Compostela, Seville
2022-05-16
By invitation
AstraZeneca
Phase 3
214
Barcelona, Girona, Madrid, Marbella, Santiago de Compostela, Valencia
2022-04-19
Active, closed
AstraZeneca
Phase 3
1,051
Barcelona, Granada, Madrid, Santiago de Compostela, Valencia
2022-02-07
Active, closed
AstraZeneca
Phase 3
367
Barcelona, Madrid, Santiago de Compostela, Seville, Valencia
2021-06-08
Active, closed
AstraZeneca
Phase 3
893
Barcelona, Granada, Lleida, Madrid, Málaga, Pamplona, Santiago de Compostela
2021-05-10
Active, closed
AstraZeneca
Phase 3
724
Badajoz, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, San Sebastián, Santiago de Compostela, Seville
2019-03-06
Active, closed
AstraZeneca
Phase 2
154
Barcelona, Madrid, Málaga, Santiago de Compostela
2018-03-16
Active, closed
AstraZeneca
Phase 3
1,126
Badajoz, Badalona, Barcelona, Elche(Alicante), Madrid, Pozuelo de Alarcón, Santiago de Compostela, Seville
2015-11-02
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/santiago-de-compostela

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Santiago de Compostela that also match the filters currently applied.

How many clinical trials are recruiting in Santiago de Compostela?

8 of the 21 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Santiago de Compostela), 21 studies
PhaseStudiesRecruitingShare
Phase 314466.7%
Phase 24219%
Observational219.5%
Phase 1/2114.8%

Most active sponsors

Lead sponsors with the most studies (Santiago de Compostela)
Lead sponsorStudiesRecruiting
AstraZeneca218
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.